Breast Cancer News

• Exercise During Active Cancer Treatment: New ASCO Guideline A new ASCO guideline recommends physical activity during cancer treatment, but notes that there is insufficient evidence to recommend specific diets or intentional weight loss or gain.
  Medscape Medical News, May 23, 2022
• New Image-Based Risk Model Helps Predict Future Breast Cancers An automated risk model using digital breast tomosynthesis images can identify women at high risk for developing cancer before their next screening exam.
  Medscape Medical News, May 19, 2022
• Medicine, AI, and Bias: Will Bad Data Undermine Good Tech? Artificial Intelligence models may help predict and prevent diseases. But recent research highlights the challenges they face in providing insights that work for all.
  WebMD Health News, May 18, 2022
• Mastectomy May Not Be Necessary for Young Breast Cancer Patients Mastectomies among younger women with nonmetastatic invasive breast cancer may not always be necessary, suggests a study that shows survival outcomes are similar after a lumpectomy.
  Medscape Medical News, May 17, 2022
• Sarcopenia Nearly Doubles Risk Women Will Quit Endocrine Therapy But the good news is oncologists can address the condition before starting therapy. The study was published as a preprint and has not yet been peer reviewed.
  First Look, May 17, 2022
• How to Weed Out False Positives on Breast MRIs Several features of incidental lesions detected on contrast-enhanced breast MRI were associated with false positive outcomes. The study, published as a preprint, has not yet been peer reviewed.
  First Look, May 16, 2022
• Cancer and COVID: What Can Increase Risk of Dying? A large meta-analysis suggests that younger age and lung and blood cancers, as well as treatment with chemotherapy, raise the risk for death from COVID-19.
  Medscape Medical News, May 13, 2022
• Nearly 234,000 Cancer Cases Predicted in Canada This Year Although overall cancer rates are declining in Canada, the number of cases and deaths continue to climb due to population growth and an aging population.
  Medscape Medical News, May 13, 2022
• Risk of Dying From New Cancer Higher in Young Cancer Survivors Adolescent and young adult cancer survivors are at an increased risk of developing and dying from a second primary cancer, highlighting the critical role of surveillance and survivorship care.
  Medscape Medical News, May 12, 2022
• ESMO BCC 2022 Twenty Years and Counting: Tamoxifen Benefit in Breast Cancer New data from a 20-year follow-up of patients with ER-positive/HER2-negative breast cancer identifies those who have lasting benefit from tamoxifen.
  Medscape Medical News, May 11, 2022
• ESMO BCC 2022 Uninformed Breast Cancer Patients Are Making Treatment Decisions Women with ductal carcinoma in situ (DCIS) are generally uninformed about their diagnosis and are making uninformed treatment decisions, concludes a Dutch study.
  Medscape Medical News, May 11, 2022
• Breast Cancer Test Recommended for Extended Endocrine Therapy The Breast Cancer Index is the only genomic test that should be used to guide extended endocrine therapy decisions for women with early-stage, hormone receptor–positive breast cancer, says ASCO.
  Medscape Medical News, May 10, 2022
• Alert FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer With a standard approval from the FDA, the HER2-directed antibody drug conjugate can now be used earlier in treatment to delay disease progression.
  FDA Approvals, May 05, 2022
• Proton-Beam Therapy Increasingly Popular in the US Physicians in the US are increasingly using proton-beam therapy to treat newly diagnosed cancer patients, a new study finds.
  Reuters Health Information, May 05, 2022
• ESMO BCC 2022 Promising Antitumor Activity After One ADC Dose in Breast Cancer Early data suggest that the antibody drug conjugate patritumab deruxtecan increases antitumor activity in early-stage breast cancer after a single dose.
  Medscape Medical News, May 05, 2022
• ESMO BCC 2022 Misconceptions Remain on Gene Signature Use in Breast Cancer Most specialists reached a consensus, although some may require more education on the clinical utility of breast cancer multigene signatures in early-stage disease, experts say.
  Medscape Medical News, May 05, 2022
• ESMO BCC 2022 'No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer However, combining nivolumab with trastuzumab deruxtecan in advanced, pretreated breast cancer did demonstrate antitumor activity, new data show.
  Medscape Medical News, May 05, 2022
• ACP-IM 2022 Bone, Breath, Heart, Guts: Eight Essential Papers in Primary Care At the 2022 ACP-IM meeting, editors from the Annals of Internal Medicine highlighted recent papers with key implications for internal medicine clinicians.
  Medscape Medical News, May 04, 2022
• More Anxiety Ups Peripheral Neuropathy Risk in Breast Cancer Depression, however, does not appear to affect chemotherapy-induced peripheral neuropathy risk. The study was published on as a preprint and has not yet been peer reviewed.
  First Look, May 04, 2022
• Substantial Toxic Effects of Breast Radiotherapy Often Missed Substantial Toxic Effects of Breast Radiotherapy Often Missed
  Medscape Medical News, April 29, 2022